WallStreetZenWallStreetZen

NYSE: BIO
Bio Rad Laboratories Inc Earnings & Revenue

Open Broker Account
OverviewForecastEarnings
DividendOwnership

BIO past revenue growth

How has BIO's revenue growth performed historically?
Company
-5.87%
Industry
10.28%
Market
185.33%
BIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
BIO's revenue has grown slower... subscribe to Premium to read more.
Revenue Growth vs Market Performance
BIO's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance

BIO earnings and revenue history

Current Revenue
$2.8B
Current Earnings
-$6.0B
Current Profit Margin
-215.2%

BIO Return on Equity

Current Company
-58.6%
Current Industry
8.2%
Current Market
-8.3%
BIO's Return on Equity (-58.6%)... subscribe to Premium to read more.
High Return on Equity Performance

Be the first to know when BIO announces earnings.

BIO Return on Assets

Current Company
-42.4%
Current Industry
5%
BIO is generating lower Return... subscribe to Premium to read more.
Above Average Return on Assets Performance

BIO Return on Capital Employed

Current Company
-68.02%
Current Industry
7.7%
BIO's ability to generate Return... subscribe to Premium to read more.
Increasing Return on Capital Employed Performance

BIO vs Medical Device Stocks

TickerRevenueEBITDAEarningsY/Y RevenueY/Y Earnings
BIO$2.80B-$7.81B-$6.03B+5.85%N/A
SNN$5.21B$1.23B$524.00M+2.22%-10.42%
BRKR$2.51B$498.70M$274.90M+8.00%+14.14%
ALGN$3.86B$855.63M$510.76M+23.49%+14.11%
SWAV$429.89M$97.73M$88.03M+227.44%N/A
View Top Medical Device Stocks

Bio Rad Laboratories Earnings & Revenue FAQ

What were BIO's earnings last quarter?

On Invalid Date, Bio Rad Laboratories (NYSE: BIO) reported Q3 2022 earnings per share (EPS) of -$5.52, up 104.19% year over year. Total Bio Rad Laboratories earnings for the quarter were -$164.23 million. In the same quarter last year, Bio Rad Laboratories's earnings per share (EPS) was $131.75.

If you're new to stock investing, here's how to buy Bio Rad Laboratories stock.

What was BIO's earnings growth in the past year?

As of Q4 2022, Bio Rad Laboratories's earnings has grown year over year. Bio Rad Laboratories's earnings in the past year totalled -$6.03 billion.

What was BIO's revenue last quarter?

On Invalid Date, Bio Rad Laboratories (NYSE: BIO) reported Q3 2022 revenue of $680.80 million up 8.87% year over year. In the same quarter last year, Bio Rad Laboratories's revenue was $747.05 million.

What was BIO's revenue growth in the past year?

As of Q4 2022, Bio Rad Laboratories's revenue has grown -5.87% year over year. This is 16.15 percentage points lower than the US Medical Devices industry revenue growth rate of 10.28%. Bio Rad Laboratories's revenue in the past year totalled $2.80 billion.
©2022 WallStreetZen
Company
AboutBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContact
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market Industries
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
Social
TwitterYouTube
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.